{"id":232845,"date":"2026-03-09T02:07:58","date_gmt":"2026-03-09T07:07:58","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/03\/effect-of-low-dose-dobutamine-infusion-on-n-terminal-pro-b-type-natriuretic-peptide-in-at-risk-patients-with-acute-myocardial-infarction-dobermann-d-a-randomized-clinical-trial"},"modified":"2026-03-09T02:07:58","modified_gmt":"2026-03-09T07:07:58","slug":"effect-of-low-dose-dobutamine-infusion-on-n-terminal-pro-b-type-natriuretic-peptide-in-at-risk-patients-with-acute-myocardial-infarction-dobermann-d-a-randomized-clinical-trial","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/03\/effect-of-low-dose-dobutamine-infusion-on-n-terminal-pro-b-type-natriuretic-peptide-in-at-risk-patients-with-acute-myocardial-infarction-dobermann-d-a-randomized-clinical-trial","title":{"rendered":"Effect of Low-Dose Dobutamine Infusion on N-Terminal Pro\u2013B-Type Natriuretic Peptide in At-Risk Patients With Acute Myocardial Infarction (DOBERMANN-D): A Randomized Clinical Trial"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/effect-of-low-dose-dobutamine-infusion-on-n-terminal-pro-b-type-natriuretic-peptide-in-at-risk-patients-with-acute-myocardial-infarction-dobermann-d-a-randomized-clinical-trial2.jpg\"><\/a><\/p>\n<p>In AMI patients at risk of in-hospital CS development, early dobutamine infusion did not reduce NT-proBNP plasma concentration but reduced SBP with no safety concerns.<\/p>\n<p>JACC CRT2026<\/p>\n<hr>\n<p>The Journal of the American College of Cardiology (JACC) stands as a leading global resource for impactful cardiovascular research, delivering essential peer-reviewed articles and crucial clinical practice guidelines. Gain access to authoritative medical content and vital CME resources designed to advance cardiovascular medicine and improve heart patient outcomes.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In AMI patients at risk of in-hospital CS development, early dobutamine infusion did not reduce NT-proBNP plasma concentration but reduced SBP with no safety concerns. JACC CRT2026 The Journal of the American College of Cardiology (JACC) stands as a leading global resource for impactful cardiovascular research, delivering essential peer-reviewed articles and crucial clinical practice guidelines. [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-232845","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/232845","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=232845"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/232845\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=232845"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=232845"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=232845"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}